Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma
Clinical trial NCT02723006 · TERMINATED
Trial details
- NCT number
- NCT02723006
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-22
- Primary completion
- 2018-05-11
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.